USPTO announces extension of certain patent and trademark-related timin g deadlines under the Coronavirus Aid, Relief, and Economic Security Act

by John Roberts on March 31, 2020

Having trouble viewing this email? View it as a Web page.
Divider

USPTO Alert

USPTO-footer-graphic
USPTO announces extension of certain patent and trademark-related timing deadlines under the Coronavirus Aid, Relief, and Economic Security Act
The United States Patent and Trademark Office (USPTO) today announced extensions to the time allowed to file certain patent and trademark-related documents and to pay certain required fees. These actions are an exercise of temporary authority provided to the USPTO by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) signed by President Trump on March 27.

“Inventors and entrepreneurs are the lifeblood of our economy, and we recognize that many of them are having difficulty as a result of COVID-19,” said Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office Andrei Iancu. “As a result, we are working to provide as much relief as possible to our stakeholders, consistent with our ability to maintain the USPTO’s fee-funded operations. We are especially mindful of the outsized impact on small businesses and independent inventors, and we have provided additional relief for these groups. Ultimately, our goal is to ensure not only that inventors and entrepreneurs can weather the storm, but that they can also hit the ground running once it passes.”

The USPTO has made operational adjustments to keep its employees and the public safe as it remains open for business. In-person meetings, such as hearings and examiner interviews, are being conducted virtually by phone and video until further notice.

Read more details in the official Patent and Trademark notices on our website. The USPTO will continue to evaluate the evolving situation around COVID-19 and its impacts on the USPTO’s operations and stakeholders.

Patent-related inquiries concerning this notice may be directed by email to Covid19PatentsRelief and by telephone to the Office of Patent Legal Administration at (571) 272-7704 or (571) 272-7703 for reexamination.

PTAB-related inquiries concerning this notice may be directed to (571) 272-9797 or by email at Trials (for AIA trials), PTAB_Appeals_Suggestions (for PTAB appeals) or InterferenceTrialSection (for interferences).

Trademark-related inquiries concerning this notice may be directed to the Trademark Office of Petitions by telephone at (571) 272-8950 or by email at TMPolicy.

TTAB-related inquiries concerning this notice may be directed to Cheryl Butler at (571) 272-4259 or Cheryl.Butler or to Denise DelGizzi at (571) 272-4265 or Denise.DelGizzi.

facebook
twitter
youtube
linkedin
Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website subscriptioncenter.

uspto

{ 0 comments… add one now }

Previous post:

Next post: